Research Diagnosis Related Groups (DRG) level LOS quality outcomes for St. Mary Medical Center located at 1050 Linden Ave, Long Beach, CA, 90813 & includes data from NPIs 1194840421
Dexur analyzed Q2 2019 (April to June 2019) Medicare claims data to benchmark length of stay (LOS) outcomes for St. Mary Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Apr 2019 to Jun 2019) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 492 | 442 | ||||||||||
| Surgical | 102 | 98 | ||||||||||
| Non Surgical | 390 | 344 | ||||||||||
| General Medicine | 149 | 136 | ||||||||||
| Cardiovascular | 96 | 84 | ||||||||||
| Pulmonology | 50 | 43 | ||||||||||
| Neurology | 40 | 34 | ||||||||||
| Orthopedics | 37 | 33 | ||||||||||
| Urology | 35 | 34 | ||||||||||
| General Surgery | 34 | 33 | ||||||||||
| Gastroenterology & Endocrinology | 30 | 27 | ||||||||||
| Oncology & Hematology | 12 | NA |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Apr 2019 to Jun 2019) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Apr 2019 to Jun 2019) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Apr 2019 to Jun 2019) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Apr 2019 to Jun 2019) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| Kidney And Urinary Tract Infections |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Apr 2019 to Jun 2019) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Apr 2019 to Jun 2019) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage |